2024-09-03 - Analysis Report
## INTU Stock Analysis

**Company Overview:** INTU, or Intuitive Surgical, is a leading provider of robotic-assisted surgical systems and instruments.

**Performance Analysis:**

1. **Relative Performance:** 
   - INTU has outperformed the S&P 500 (VOO) by a significant margin, with a cumulative return of 149.62% compared to VOO's 89.66%. This difference results in a 59.96% outperformance, placing it at the 43.23rd percentile relative to historical performance.

2. **Recent Price Movement:**
   - **Closing Price:** 630.26
   - **5-day Moving Average:** 622.71
   - **20-day Moving Average:** 634.82
   - **60-day Moving Average:** 631.17
   - The stock is currently trading above its 5-day and 60-day moving averages, suggesting short-term bullish momentum. However, it is slightly below its 20-day moving average, hinting at potential short-term consolidation.

3. **Technical Indicators:**
   - **RSI:** 50.97 - The RSI is hovering around the neutral level of 50, indicating neither overbought nor oversold conditions.
   - **PPO:** -0.45 - The PPO is negative, indicating that the short-term moving average is lagging behind the long-term moving average, suggesting potential downward pressure.
   - **Delta_Previous_Relative_Divergence:** -5.59 - The recent decline in relative divergence suggests a short-term downtrend.
   - **Expected Return:** 78.84% - The projected return over the next 5 years indicates significant potential for growth.

4. **Recent Earnings and Outlook:**

   | Date | EPS | Revenue |
   |---|---|---|
   | 2024-05-23 | 8.53 | 6.74 B$ |
   | 2024-02-22 | 1.26 | 3.39 B$ |
   | 2023-11-28 | 0.86 | 2.98 B$ |
   | 2023-05-23 | 7.44 | 6.02 B$ |
   | 2024-05-23 | 7.44 | 6.02 B$ |

   - **Most recent earnings (2024-05-23):** INTU exceeded analysts' EPS estimates, reporting $8.53 compared to the anticipated $7.44. Revenue also surpassed expectations at $6.74 billion.  This strong performance demonstrates the company's continued growth and market dominance in the robotic surgery sector.

**Summary:**

INTU remains a strong performer with a robust long-term growth outlook. While recent technical indicators suggest potential short-term consolidation, the strong earnings report and high expected return indicate a promising future. The company's leadership position in the robotic surgery market, coupled with its consistent outperformance compared to the S&P 500, makes INTU a compelling investment opportunity for investors seeking long-term growth potential. 
